Both in Pharmaceuticals
Journey Medical vs MacroGenics
Over the past year DERM returned −39.3% and MGNX returned +51.9%; their daily moves had a correlation of 0.19.
DERM −39.3% MGNX +51.9%Growth of $1, one year, split-adjusted
| Metric | DERM | MGNX |
|---|---|---|
| Price | $5.17 | $2.40 |
| Market cap | $145.9M | $152.9M |
| Today | −4.44% | +0.84% |
| 1 month | −23.1% | −33.3% |
| 6 months | −0.4% | −23.3% |
| Year to date | −32.9% | +49.1% |
| 1 year | −34.9% | +42.0% |
| Revenue growth (YoY) | +18.9% | +378.0% |
| Gross margin | 65.6% | 100.0% |
| Net margin | −1.7% | 59.4% |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | 0.9× |
| Net cash | -$245.0K | $173.3M |
| Dividend yield | — | — |
| Volatility (60d) | 62.4% | 113.8% |
| Short % of float | 24.8% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).